The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer
Tino Vollmer, Stephan Schlickeiser, Leila Amini, Sarah Schulenberg, Désirée J. Wendering, Viqar Banday, Anke Jurisch, Rebecca Noster, Désirée Kunkel, Nicola Brindle, Ioannis Savidis, Levent Akyüz, Jochen Hecht, Ulrik Stervbo, Toralf Roch, Nina Babel, Petra Reinke, Ola Winqvist, Amir Sherif, Hans‐Dieter Volk, Michael Schmueck‐Henneresse
Abstract
T cells that is predictive of chemotherapy responsiveness in MIBC. This may offer immunotherapeutic options for targeted activation of intratumoral stem-like T cells in solid tumors.
Topics & Concepts
CXCR3CXCL11ChemokineMedicineBladder cancerCancer researchChemotherapyCancerOncologyChemokine receptorImmunologyInternal medicineInflammationImmunotherapy and Immune ResponsesBladder and Urothelial Cancer TreatmentsImmune cells in cancer